We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMS icon
426
CMS Energy
CMS
$23.1B
$2.05M 0.04%
45,751
-441
-1% -$19.1K
ODP
427
DELISTED
ODP
ODP
$2.05M 0.04%
43,884
– –
PPL
428
PPL Corp
PPL
$27.3B
$2.05M 0.04%
54,757
+11,435
+26% +$409K
MCO icon
429
Moody's
MCO
$81.7B
$2.04M 0.04%
18,250
+5,066
+38% +$543K
HCM icon
430
HUTCHMED
HCM
$1.89B
$2.04M 0.04%
+102,000
New +$1.53M
MCK icon
431
McKesson
MCK
$98.5B
$2.03M 0.04%
13,715
+3,398
+33% +$498K
AKAO
432
DELISTED
Achaogen Inc
AKAO
$2.03M 0.04%
80,555
-9,445
-10% -$194K
OMED
433
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.97M 0.04%
214,000
+7,000
+3% +$61.5K
PLD icon
434
Prologis
PLD
$138B
$1.94M 0.04%
37,424
+6,223
+20% +$317K
MGM icon
435
MGM Resorts International
MGM
$11.7B
$1.93M 0.04%
70,543
+6,296
+10% +$175K
STZ icon
436
Constellation Brands
STZ
$22.2B
$1.9M 0.04%
11,726
-1,878
-14% -$293K
AVXS
437
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.9M 0.04%
+25,000
New +$1.55M
UTHR icon
438
United Therapeutics
UTHR
$26.3B
$1.9M 0.04%
14,000
– –
BIO icon
439
Bio-Rad Laboratories Class A
BIO
$8.42B
$1.89M 0.04%
9,500
– –
NOV icon
440
NOV
NOV
$7.45B
$1.89M 0.04%
47,234
+6,123
+15% +$239K
MKC icon
441
McCormick & Company Non-Voting
MKC
$13.4B
$1.88M 0.04%
38,470
+33,936
+748% +$1.64M
KDP icon
442
Keurig Dr Pepper
KDP
$40.4B
$1.87M 0.04%
19,135
+2,294
+14% +$214K
PARA
443
DELISTED
Paramount Global Class B
PARA
$1.86M 0.04%
26,840
+4,824
+22% +$317K
PNW icon
444
Pinnacle West Capital
PNW
$12.9B
$1.85M 0.04%
+22,233
New +$1.78M
TTPH
445
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.85M 0.04%
10,050
-8,650
-46% -$970K
SRE icon
446
Sempra
SRE
$60.8B
$1.84M 0.04%
33,228
+6,846
+26% +$363K
WELL icon
447
Welltower
WELL
$178B
$1.83M 0.04%
25,791
+6,574
+34% +$444K
TRI icon
448
Thomson Reuters
TRI
$39.4B
$1.82M 0.04%
36,286
-68,777
-65% -$3.51M
BF.B icon
449
Brown-Forman Class B
BF.B
$12B
$1.81M 0.04%
61,316
+1,978
+3% +$58.8K
ED icon
450
Consolidated Edison
ED
$41.6B
$1.81M 0.04%
23,316
+4,650
+25% +$350K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.